Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126274562 | 12627456 | 2 | F | 2016 | 20160728 | 20160805 | 20160808 | EXP | US-ABBVIE-16K-163-1688130-00 | ABBVIE | 0.00 | F | Y | 0.00000 | 20160808 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126274562 | 12627456 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QOW | ||||||
| 126274562 | 12627456 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QOW | ||||||
| 126274562 | 12627456 | 3 | SS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Unknown | UNKNOWN | 20725 | ||||||||||
| 126274562 | 12627456 | 4 | SS | ELMIRON | PENTOSAN POLYSULFATE SODIUM | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 126274562 | 12627456 | 5 | C | METHADONE | METHADONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126274562 | 12627456 | 6 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126274562 | 12627456 | 7 | C | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | 0 | ||||||||||||
| 126274562 | 12627456 | 8 | C | COPPER | COPPER | 1 | 0 | ||||||||||||
| 126274562 | 12627456 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 126274562 | 12627456 | 10 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126274562 | 12627456 | 1 | Crohn's disease |
| 126274562 | 12627456 | 3 | Product used for unknown indication |
| 126274562 | 12627456 | 4 | Product used for unknown indication |
| 126274562 | 12627456 | 5 | Product used for unknown indication |
| 126274562 | 12627456 | 6 | Product used for unknown indication |
| 126274562 | 12627456 | 7 | Product used for unknown indication |
| 126274562 | 12627456 | 8 | Product used for unknown indication |
| 126274562 | 12627456 | 9 | Product used for unknown indication |
| 126274562 | 12627456 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126274562 | 12627456 | OT |
| 126274562 | 12627456 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126274562 | 12627456 | Abnormal faeces | |
| 126274562 | 12627456 | Colectomy | |
| 126274562 | 12627456 | Cystitis interstitial | |
| 126274562 | 12627456 | Dyspepsia | |
| 126274562 | 12627456 | Gastric disorder | |
| 126274562 | 12627456 | Nephrolithiasis | |
| 126274562 | 12627456 | Neuropathy peripheral | |
| 126274562 | 12627456 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |